在患有长期2型糖尿病的糖尿病外围神经病变患者中降低了葡萄糖素
Ziyang Shen1, Mengxing Chen2, Qian Li1
1Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210000, China.
Postgraduate medical journal
|April 22, 2024
概括
禁食C-和葡萄糖水平与2型糖尿病 (T2DM) 患者的糖尿病外围神经病变 (DPN) 有不同的关联. 降低葡萄糖与长期T2DM中的DPN有关.
科学领域:
- 内分泌学 在内分泌学.
- 糖尿病学 糖尿病学
- 神经学 神经学
背景情况:
- 糖尿病外围神经病变 (DPN) 是2型糖尿病 (T2DM) 的常见并发症.
- 了解小岛功能标记物和DPN之间的关系对于风险分层和风险管理至关重要.
- 禁食C-和葡萄糖是岛屿功能和葡萄糖代谢的关键指标.
研究的目的:
- 在T2DM患者中调查禁食C-,葡萄糖和DPN之间的关联.
- 探索糖尿病持续时间如何影响这些关联.
- 评估葡萄糖素对DPN的预测价值.
主要方法:
- 797名T2DM患者的队列接受了全面的DPN风险因素评估.
- 患者被分为短期 (≤10年) 和长期 (>10年) 糖尿病组.
- 使用了后勤回归和接收器运行特征 (ROC) 曲线分析.
主要成果:
- 较低的禁食C-水平与短期组的DPN有关.
- 在长期治疗组中,在DPN患者中特别观察到降低的葡萄糖水平.
- 葡萄糖成为长期队列中DPN的唯一显著风险因素,在ROC分析中AUC为0.706.
结论:
- 血清葡萄糖水平显示T2DM患者与DPN的双向变化,取决于糖尿病持续时间.
- 降低葡萄糖是长期T2DM患者中DPN的重要危险因素.
相关概念视频
Hypoglycemia and Glucagon
257
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Glucagon-like Receptor Agonists
319
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
319
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
Dipeptidyl Peptidase 4 Inhibitors
182
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
182


